Pathstone Family Office, LLC Boston Scientific Corp Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Pathstone Family Office, LLC holds 65,263 shares of BSX stock, worth $6.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

65,263

Previous 38,967 67.48%

Holding current value

$6.82 Million

Previous $2.11 Million 63.5%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$50.19 - $54.68 $1.32 Million - $1.44 Million	26,296 Added 67.48%	65,263 $3.45 Million
Q2 2023 Jan 12, 2024	SELL	$49.72 - $54.64 $1.31 Million - $1.44 Million	-26,296 Reduced 40.29%	38,967 $2.11 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $144,038 - $158,292	-2,897 Reduced 6.92%	38,967 $2.11 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $1.05 Million - $1.17 Million	-23,366 Reduced 35.82%	41,864 $2.09 Million
Q4 2022 Oct 23, 2023	BUY	$39.56 - $47.22 $1.11 Million - $1.32 Million	28,060 Added 75.49%	65,230 $3.02 Million
Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $353,270 - $421,674	8,930 Added 15.86%	65,230 $3.02 Million
Q3 2022 Oct 23, 2023	BUY	$36.71 - $109.66 $556,560 - $1.66 Million	15,161 Added 68.89%	37,170 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $782,179 - $2.34 Million	21,307 Added 60.89%	56,300 $2.18 Million
Q2 2022 Oct 23, 2023	SELL	$35.24 - $47.1 $597,599 - $798,721	-16,958 Reduced 43.52%	22,009 $820,000
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $350,884 - $468,974	9,957 Added 39.77%	34,993 $1.31 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $431,576 - $475,895	10,552 Added 72.85%	25,036 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $16,179 - $19,069	-425 Reduced 2.85%	14,484 $616,000
Q3 2021 Nov 16, 2021	BUY	$41.23 - $45.88 $46,878 - $52,165	1,137 Added 8.26%	14,909 $647,000
Q2 2021 Aug 31, 2021	BUY	$38.58 - $44.24 $53,896 - $61,803	1,397 Added 11.29%	13,772 $589,000
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $46,415 - $52,205	1,316 Added 11.9%	12,375 $478,000
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $32,089 - $40,626	968 Added 9.59%	11,059 $398,000
Q1 2020 Jun 11, 2020	BUY	$25.83 - $45.71 $2,350 - $4,159	91 Added 0.91%	10,091 $329,000
Q1 2020 May 07, 2020	SELL	$25.83 - $45.71 $4,416 - $7,816	-171 Reduced 1.68%	10,000 $326 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $3,029 - $3,629	80 Added 0.79%	10,171 $4.6 Million
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $201,550 - $217,250	-5,000 Reduced 33.13%	10,091 $411,000
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $174,549 - $214,899	5,000 Added 49.55%	15,091 $648,000
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $2,994 - $3,708	91 Added 0.91%	10,091 $387,000
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $247,900 - $298,000	10,000	10,000 $248,000

Others Institutions Holding BSX

# of Institutions

1,663

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Boston Scientific Corp Transaction History